English

Platelet functional responses and signalling: the molecular relationship. Part 1: responses.

Introduction

The process of hemostasis is a spatiotemporally regulated physiological response
aiming to stop bleeding upon vascular injury. Blood platelets play a critical role in this response. They actually have a number of critical roles in human physiology, which include formation of the hemostatic plug upon injury
[
2
Novel mouse hemostasis model for real-time determination of bleeding time and hemostatic plug composition.

Getz TM, Piatt R, Petrich BG, Monroe D, Mackman N, Bergmeier W.

Journal of Thrombosis and Haemostasis . 2015, 13, 417-425

]
, acceleration of the membrane-dependent reactions of blood coagulation
[
3,
Kinetics of Factor X activation by the membrane-bound complex of Factor IXa and Factor VIIIa.

Panteleev MA, Saenko EL, Ananyeva NM, Ataullakhanov FI.

Biochemistry Journal. 2004, 381, 779-794

4
Hysteresis-like binding of coagulation factors X/Xa to procoagulant activated platelets and phospholipids results from multistep association and membrane-dependent multimerization.

Podoplelova NA, Sveshnikova AN, Kurasawa JH, Sarafanov AG, Chambost H, Vasil’Ev SA, et al.

BiomemBiochimica et Biophysica Acta (BBA)-Biomembranesbranes. 2016, 1858, 1216-1227

]
, maintenance of vascular integrity
, modulation of immune responses
[
8,
Platelet ITAM signaling is critical for vascular integrity in inflammation.

Boulaftali Y, Hess PR, Getz TM, Cholka A, Stolla M, Mackman N, et al.

Journal of Clinical Investigation. 2013, 123 (2), 908-916

9,
Editorial: Platelets and Immune Responses During Thromboinflammation.

Schattner M, Jenne CN, Negrotto S, Ho-Tin-Noe B.

Frontiers in Immunology. 2020, 11, 1079

10
he dual role of platelet-innate immune cell interactions in thrombo-inflammation.

Rayes J, Bourne JH, Brill A, Watson SP.

Research and Practice in Thrombosis and Haemostasis. 2020, 4, 23-35

]
, tissue growth and regeneration
[
12
Platelets and cancer angiogenesis nexus.

Wojtukiewicz MZ, Sierko E, Hempel D, Tucker SC, Honn KV.

Cancer and Metastasis Reviews. 2017, 36, 249-262

]
. In order to perform these urgent functions when and where it is needed, platelets rely on their huge network of receptors and signal transduction pathways.
The functional responses of platelets to stimulation are numerous
[
13
Platelets and hemostasis.

Panteleev MA, Sveshnikova AN.

Oncohematology. 2014, 9, 65-73

]
(Fig. 1), and the number of positive and negative stimuli to be processed by the cellular signalling networks in order to make correct decisions is likewise not small
. Additionally, a number of platelet inhibitory signals has been identified in recent years
. As a result, the network of platelet signal transduction that is initiated by at least ten major receptors, goes through multiple interconnected pathways and ends up with various responses of different degree might appear quite terrifying (Fig. 2).
Scheme of the main platelet functional responses to activation (all of them could be blocked by inhibition)
Figure 1. Scheme of the main platelet functional responses to activation (all of them could be blocked by inhibition)
Scheme of the relationship between platelet-activating agents (thrombin, ADP, collagen, thromboxane A2, vWF, podoplanin and adrenalin) and platelet functional responses (shape change depicted by filopodia formation, adhesion and aggregation depicted by integrin activation, granule secretion and thromboxane A2 synthesis).
Figure 2. Scheme of the relationship between platelet-activating agents (thrombin, ADP, collagen, thromboxane A2, vWF, podoplanin and adrenalin) and platelet functional responses (shape change depicted by filopodia formation, adhesion and aggregation depicted by integrin activation, granule secretion and thromboxane A2 synthesis).
When these pathways are reviewed and discussed, they are usually analyzed not as a network but rather as a simpler cause-and-effect chain. For example: activator X stimulates receptor Y leading to an increase of a secondary messenger Z that mediates further downstream events, including responses “1”, “2”, and “3”. The interplay of different receptors that could work cooperatively or downregulate each other is often overlooked. Interestingly, in other fields like immunology, terms like "co-activator" or "co-receptor" have already became accepted
[
17,
IκBβ is an essential co-activator for LPS-induced IL-1β transcription in vivo.

Scheibel M, Klein B, Merkle H, Schulz M, Fritsch R, Greten FR, et al.

ournal of Experimental Medicine . 2010, 207, 2621-2630

18
Costimulation, Coinhibition and Cancer.

Inman BA, Frigola X, Dong H, Kwon ED.

Current Cancer Drug Targets . 2007, 7, 15-30

]
. Likewise, transformation of the signal along the signalling pathway, different dose-dependence for different responses to the same agonist caused by it, principles of signal encoding and de-coding are rarely discussed even beyond the platelet field
[
19
A Directed Protein Interaction Network for Investigating Intracellular Signal Transduction.

Vinayagam A, Stelzl U, Foulle R, Plassmann S, Zenkner M, Timm J, et al.

Science Signaling. 2011, 4, rs8

]
, and almost never for platelets.
Another not usually discussed point in platelet receptor-response relationship is the mechanosensitivity of these cells, whose whole life is spent in fast streams of blood. There is enough evidence that platelets can “sense” the shear rate of the blood stream and even turbulence of the flow
[
20,
Platelet Mechanotransduction.

Hansen CE, Qiu Y, McCarty OJT, Lam WA.

Annual Review of Biomedical Engineering. 2018, 20, 253-275

22,
Evidence for shear-mediated Ca2+ entry through mechanosensitive cation channels in human platelets and a megakaryocytic cell line.

Ilkan Z, Wright JR, Goodall AH, Gibbins JM, Jones CI, Mahaut-Smith MP.

Journal of Biological Chemistry. 2017, 292, 9204-9217

]
. However, this question will be discussed in the next part of this review, as here our goal is to address issues of responses rather than receptors. We shall highlight the main principles of platelet signal processing and decision-making, with the focus not on the description of signalling pathways but rather on the attempt to characterize how they work together to achieve different sets of physiologically relevant responses depending on the situation.
 

Functional responses and their immediate causes

Here we shall mostly focus on the platelet responses relevant to hemostasis, because they are believed to be more comprehensively studied. The minimal set of main platelet functions implemented in response to injury usually includes integrin αIIbβ3 activation
[
24
Platelet Integrin αIIbβ3: Mechanisms of Activation and Clustering; Involvement into the Formation of the Thrombus Heterogeneous Structure.

Kaneva VN, Martyanov AA, Morozova DS, Panteleev MA, Sveshnikova AN.

Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology. 2019, 13, 97-110

]
, dense granule release
, alpha-granule release
[
26
Selective sorting of alpha-granule proteins.

Jr JEI, Battinelli EM.

Journal of Thrombosis and Haemostasis. 2009, 7, 173-176

]
, thromboxane A2 synthesis, shape change, procoagulant activity
[
27
Clot contraction drives the translocation of procoagulant platelets to thrombus surface.

Nechipurenko DY, Receveur N, Yakimenko AO, Shepelyuk TO, Yakusheva AA, Kerimov RR, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology. 2019, 39, 37-47

]
, and contraction
[
28
Kinetics and mechanics of clot contraction are governed by the molecular and cellular composition of the blood.

Tutwiler V, Litvinov RI, Lozhkin AP, Peshkova AD, Lebedeva T, Ataullakhanov FI, et al.

Blood. 2016, 127, 149-159

]
(Fig. 1). The initial adhesion to von Willebrand factor mediated by glycoprotein Ib is not included among them because it does not require platelet activation
. It should be noted that these functions are probably not equally important, or rather not all of them were reliably shown to contribute to hemostatis.

Integrin activation.

Integrin activation is probably the one response believed to be the most vitally important as demonstrated by severe bleeding in their deficiency, Glanzmann's thrombasthenia
. Platelets have about 100000 integrin αIIbβ3 molecules per cell that are capable to radically increase their affinity to von Willebrand factor and fibrinogen thus directly mediating aggregate formation
[
24
Platelet Integrin αIIbβ3: Mechanisms of Activation and Clustering; Involvement into the Formation of the Thrombus Heterogeneous Structure.

Kaneva VN, Martyanov AA, Morozova DS, Panteleev MA, Sveshnikova AN.

Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology. 2019, 13, 97-110

]
. All platelet agonists, including biomechanical platelet activation via the vWf-glycoprotein Ib axis, are believed to cause integrin activation to some degree
. This response is gradual, probably with the intermediate activation states
. The immediate cause of the integrin transition between the states is formation of a large cytoskeleton-associated complex of proteins at the cytosolic side of the plasmatic membrane. The critical structural role in this complex is played by proteins talin-1
[
32
Talin-1 is the principal platelet Rap1 effector of integrin activation.

Lagarrigue F, Paul DS, Gingras AR, Valadez AJ, Sun H, Lin J, et al.

Blood. 2020, 136, 1180-1190

]
and kindlin-3
[
33
Kindlin supports platelet integrin αIIbβ3 activation by interacting with paxillin.

Gao J, Huang M, Lai J, Mao K, Sun P, Cao Z, et al.

Journal of Cell Science. 2017, 130, 3764-3775

]
, while the signal transduction switch triggering its formation is believed to be small soluble cytosolic GTPase, Rap1-GTP
[
32,
Talin-1 is the principal platelet Rap1 effector of integrin activation.

Lagarrigue F, Paul DS, Gingras AR, Valadez AJ, Sun H, Lin J, et al.

Blood. 2020, 136, 1180-1190

34
Rap1-Rac1 circuits potentiate platelet activation.

Stefanini L, Boulaftali Y, Ouellette TD, Holinstat M, Désiré L, Leblond B, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology. 2012, 32, 434-441

]
. In addition to αIIbβ3, platelets have a number of other integrins specific to collagen, fibronectin, laminin and other molecules; their significance is less certain, while the activation mechanisms appear to be similar
[
35,
Platelet integrin α6β1 controls lung metastasis through direct binding to cancer cell-derived ADAM9.

Mammadova-Bach E, Zigrino P, Brucker C, Bourdon C, Freund M, De Arcangelis A, et al.

JCI Insight. 2016, 1 (14), e88245

36
he basement membrane protein nidogen-1 supports platelet adhesion and activation.

Lakshmanan HHS, Melrose AR, Sepp A-LI, Mitrugno A, Ngo ATP, Khader A, et al.

Platelets. 2020, 32 (3), 424-428

]
.

Dense granule release.

Dense (or delta-, δ-) granules are platelet-specific organelles released upon stimulation
. They contain mostly low-molecular-weight compounds, the major of them being ADP able to activate other platelets
[
39
Assessment of the effects of Syk and BTK inhibitors on GPVI-mediated platelet signaling and function.

Zheng TJ, Lofurno ER, Melrose AR, Lakshmanan HHS, Pang J, Phillips KG, et al.

American Journal of Physiology: Cell Physiology. 2021, NaN, NaN

]
. Another component that has been recently attracting a lot of attention is polyphosphate reported to have a number of potential roles in the coagulation cascade
[
40,
A Flow Cytometry-Based Assay for Procoagulant Platelet Polyphosphate.

Labberton L, Long AT, Gendler SJ, Snozek CL, Stavrou EX, Nickel KF, et al.

Cytometry Part B: Clinical Cytometry. 2018, 94, 369-373

41
Platelet polyphosphate induces fibroblast chemotaxis and myofibroblast differentiation.

Suess PM, Smith SA, Morrissey JH.

Journal of Thrombosis and Haemostasis. 2020, 18, 3043-3052

]
. The functional role of other dense granule components such is ATP, serotonin, calcium is much less clear
. In contrast to integrin activation, dense granule release is not easily mediated by all activators; for example, ADP itself causes it only to a very minor degree
[
43
The effect of P2Y12 inhibition on platelet activation assessed with aggregation- and flow cytometry-based assays.

Leunissen TC, Wisman PP, van Holten TC, de Groot PG, Korporaal SJ, Koekman AC, et al.

Platelets. 2017, 28, 567-575

]
. The intracellular mechanism of differential dense granule release is still controversial
and will be discussed in the next part of this Review. The essential signal transduction switch mediating these processes is believed to be various isoforms of protein kinase C
and phosphatidylinositol content of their membranes
.

Alpha granule release.

Alpha (α-) granules are another type of platelet not necessarily spherical
intracellular vesicles released upon activation, which have specific cargo composed mostly of proteins including fibrinogen, von Willebrand factor, factor V, C1 inhibitor, growth factors, and other molecules
[
26,
Selective sorting of alpha-granule proteins.

Jr JEI, Battinelli EM.

Journal of Thrombosis and Haemostasis. 2009, 7, 173-176

49
Platelet Releasate Proteome Profiling Reveals a Core Set of Proteins with Low Variance between Healthy Adults.

Parsons MEM, Szklanna PB, Guerrero JA, Wynne K, Dervin F, O’Connell K, et al.

Proteomics. 2018, 18, e1800219

]
. Membranes of alpha-granules have additional integrins and P-selectin. Some of the studies suggest that contact-pathway-activating components of platelets are associated with alpha granules, and not dense granules
[
50
Platelet surface-associated activation and secretion-mediated inhibition of coagulation factor XII.

Zakharova NV, Artemenko EO, Podoplelova NA, Sveshnikova AN, Demina IA, Ataullakhanov FI, et al.

PloS One. 2015, 10, e0116665

]
. There is evidence that there are subtypes of alpha-granules with different content released upon different stimulation
. The proteins in alpha-granules are involved in platelet aggregation, coagulation, angiogenesis, immunity, inflammation, vessel wall integrity maintenance/repair and other vital processes
. However, the only component of alpha granules whose hemostatic function is well established is factor V, which is present there in significant quantities and in partially activated form, and whose importance is confirmed by patient and animal studies
. Alpha-granule proteins remain associated with procoagulant platelets
by forming a fibrin polymerization-dependent and transglutaminase- dependent "cap"
[
57
Procoagulant platelets form an α-granule protein-covered “cap” on their surface that promotes their attachment to aggregates.

Abaeva AA, Canault M, Kotova YN, Obydennyy SI, Yakimenko AO, Podoplelova NA, et al.

Journal of Biological Chemistry. 2013, 288, 29621-29632

]
. Its function is not completely clear, although they were shown to mediate procoagulant platelet attachment to aggregates
[
58
Identification of different proaggregatory abilities of activated platelet subpopulations.

Yakimenko AO, Verholomova FY, Kotova YN, Ataullakhanov FI, Panteleev MA.

Biophysical Journal. 2012, 102, 2261-2269

]
. The release of alpha granules is believed to be produced by almost all platelet activators
[
59,
A simple, whole blood method for assessment of platelet function: application to dietary intervention.

Allman-Farinelli MA, Bendall L, Troy J, Versluis C, Hall D, Favaloro EJ, et al.

Thrombosis Research. 1998, 90, 163-169

60,
Close relationship between the platelet activation marker CD62 and the granular release of platelet-derived growth factor.

Graff J, Klinkhardt U, Schini-Kerth VB, Harder S, Franz N, Bassus S, et al.

Journal of Pharmacology and Experimental Therapeutics. 2002, 300, 952-957

]
.

Procoagulant activity

Acceleration of the membrane-dependent reactions of blood coagulation occurs on the surface of the specific platelet subpopulation, called procoagulant platelets; recent data suggest that there is even a special dedicated cell structure for this
[
62
Coagulation factors bound to procoagulant platelets concentrate in cap structures to promote clotting.

Podoplelova NA, Sveshnikova AN, Kotova YN, Eckly A, Receveur N, Nechipurenko DYu, et al.

Blood. 2016, 128, 1745-1755

]
. Therefore, this response is a bit different from other responses, which are more uniformly distributed among platelet. Interestingly, integrins are inactivated in this subpopulation at some timepoint of procoagulant platelet formation
[
63
Dual Mechanism of Integrin αIIbβ3 Closure in Procoagulant Platelets.

Mattheij NJA, Gilio K, van Kruchten R, Jobe SM, Wieschhaus AJ, Chishti AH, et al.

Journal of Biological Chemistry. 2013, 288, 13325-13336

]
. The procoagulant platelets are formed upon strong stimulation with thrombin or glycoprotein VI agonists as a result of necrosis process
, caused by accumulation of calcium by the mitochondria
[
66
Mechanisms of increased mitochondria-dependent necrosis in Wiskott-Aldrich syndrome platelets.

Obydennyi SI, Artemenko EO, Sveshnikova AN, Ignatova AA, Varlamova TV, Gambaryan S, et al.

Haematologica. 2020, 105, 1095-1106

]
. However, other activators such as ADP are capable of fine-tuning procoagulant platelet formation
[
67
Modulation and pre-amplification of PAR1 signaling by ADP acting via the P2Y12 receptor during platelet subpopulation formation.

Shakhidzhanov SS, Shaturny VI, Panteleev MA, Sveshnikova AN.

Biochimica et Biophysica Acta (BBA)-General Subjects. 2015, 1850, 2518-2529

]
.

Other responses

The earliest platelet response to any activation, even very slight one, is shape change from an ellipsoid to a sphere associated with reorganization of peripheral microtubule ring
[
68,
Motor-driven marginal band coiling promotes cell shape change during platelet activation.

Diagouraga B, Grichine A, Fertin A, Wang J, Khochbin S, Sadoul K.

Journal of Cell Biology. 2014, 204, 177-185

69
Tubulin in Platelets: When the Shape Matters.

Cuenca-Zamora EJ, Ferrer-Marín F, Rivera J, Teruel-Montoya R.

International Journal of Molecular Sciences. 2019, 20, NaN

]
. However, functional importance of this transition is not clear. The next level of shape change is formation of lamellipodia and filopodia leading to increased surface of contact with other platelets and vascular wall
[
70
Platelet actin nodules are podosome-like structures dependent on Wiskott-Aldrich syndrome protein and ARP2/3 complex.

Poulter NS, Pollitt AY, Davies A, Malinova D, Nash GB, Hannon MJ, et al.

Nature Communications. 2015, 6, 7254

]
. These stages are caused by actin cytoskeleton re-arrangements
, potently induced by thrombin, followed by ADP, but less by collagen
. Platelets ability to change their shape significantly affects packing of platelets within thrombus, and results in increased platelet density and decreased porosity
[
72
Platelet packing density is an independent regulator of the hemostatic response to injury.

Mirramezani M, Herbig BA, Stalker TJ, Nettey L, Cooper M, Weisel JW, et al.

Journal of Thrombosis and Haemostasis. 2018, 16, 973-983

]
. However, the necessity of this response is unclear, as the disregulated actin polymerization in patients with Wiscott-Aldrich syndrome cause smaller platelet formation rather than platelet disfunction
[
66,
Mechanisms of increased mitochondria-dependent necrosis in Wiskott-Aldrich syndrome platelets.

Obydennyi SI, Artemenko EO, Sveshnikova AN, Ignatova AA, Varlamova TV, Gambaryan S, et al.

Haematologica. 2020, 105, 1095-1106

73
WASP plays a novel role in regulating platelet responses dependent on αIIbβ3 integrin outside-in signalling.

Shcherbina A, Cooley J, Lutskiy MI, Benarafa C, Gilbert GE, Remold‐O’Donnell E.

British Journal of Haematology. 2010, 148, 416-427

]
.
Another early and easily induced response is thromboxane A2 synthesis mediated by phospholipase A2, cyclooxygenase (mostly, COX-1) and thromboxane synthase
[
74
Platelets, diabetes and myocardial ischemia/reperfusion injury.

Russo I, Penna C, Musso T, Popara J, Alloatti G, Cavalot F, et al.

Cardiovascular Diabetology. 2017, 16, NaN

]
. Thromboxane A2 is a lipid eicosanoid acting upon platelets (like ADP)
. It is still not clear whether thromboxane is important for the same platelet that has released it. At the first step, arachidonic acid is produced from different membrane phospholipids, and the second step is that of thromboxane A2 formation. Interestingly, the regulated step is the first one, that of phospholipase A2. That is why resting platelets may produce thromboxane A2 upon addition of just arachidonic acid
[
76
Is arachidonic acid stimulation really a test for the response to aspirin? Time to think again?

Olechowski B, Ashby A, Mariathas M, Khanna V, Mahmoudi M, Curzen N.

Expert Review of Cardiovascular Therapy. 2017, 15, 35-46

]
. Platelets have two phospholipases A2, C- and I- isoforms. The former is activated by slight increase of cytosolic calcium concentration, and that is probably why all classic platelet activators cause thromboxane synthesis, while the latter is activated independent of calcium and its role in platelets is not yet established
. COX-1 is inactivated by aspirin and is one of the main targets for anti-aggregation therapy, suggesting importance of thromboxane A2 in arterial thrombus formation
.
Platelet contraction, sometimes called “retraction”, occurs at a later stage of plug/thrombus formation, and is mediated by classic actin/myosin mechanisms
[
79
The critical role of myosin IIA in platelet internal contraction.

Johnson GJ, Leis LA, Krumwiede MD, White JG.

Journal of Thrombosis and Haemostasis. 2007, 5, 1516-1529

]
. Contraction is observed in platelets activated by a variety of agonists. The studies of signal transduction pathways leading to clot contraction are lacking, although integrin “outside-in” signalling is known to be crucial for this process
. Also, a calcium-dependent enzyme, myosin II light chain kinase (MLCK) is involved during clot retraction
[
81
Biphasic myosin II light chain activation during clot retraction.

Egot M, Kauskot A, Lasne D, Gaussem P, Bachelot-Loza C.

Thrombosis and Haemostasis. 2013, 110, 1215-1222

]
. Recent studies suggested that contraction may play a role in re-arranging thrombus architecture, e.g. expelling procoagulant platelets to the platelet thrombus periphery to form fibrin there
[
27
Clot contraction drives the translocation of procoagulant platelets to thrombus surface.

Nechipurenko DY, Receveur N, Yakimenko AO, Shepelyuk TO, Yakusheva AA, Kerimov RR, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology. 2019, 39, 37-47

]
, organizing ischemic thrombi
[
82
Quantitative Morphology of Cerebral Thrombi Related to Intravital Contraction and Clinical Features of Ischemic Stroke.

Khismatullin RR, Nagaswami C, Shakirova AZ, Vrtková A, Procházka V, Gumulec J, et al.

Stroke. 2020, 51, 3640-3650

]
, or increasing platelet concentration at the fibrin clot periphery, also mechanically increasing local fibrin density
[
83
Asymmetrical Forces Dictate the Distribution and Morphology of Platelets in Blood Clots.

Kovalenko TA, Giraud M-N, Eckly A, Ribba A-S, Proamer F, Fraboulet S, et al.

Cells. 2021, 10, 584

]
.
 

Conclusions

Some of the platelet responses are critical for platelet plug formation (integrins, dense granules, thromboxane A2), while others are involved in blood coagulation (procoagulant activity, alpha-granules); yet other responses while being important have less clearly defined area of applicability, such as contraction and shape change.
These responses are spatiotemporally organized: they occur at different stages in different parts of the thrombi (Fig. 3). Integrin activation of different degree is responsible for forming the whole body of the thrombus, both the dense parts of highly activated platelets and loosely activated external regions; dense granule release is vital for the activation of platelets distal from the damaged region; alpha-granules and procoagulant surfaces are vital for fibrin formation and thrombus solidification.
In order to achieve this, platelet activation responses form a hierarchy of strength: some of them are induced by all or most agonists (alpha granule release, weak integrin activation), while others require potent stimulation (procoagulant activity), with all shades of gray in-between. Some of the responses are gradual meaning that the response is gradually increased within a wide range of activation conditions (dense granules), while others are trigger-like meaning that they either completely implemented or not at all (alpha granules).
The in-depth analysis of the signalling pathways interaction, encoding and decoding of information, which give rise to these properties, are considered in the next part of this review. As a post-note it is worth mentioning that the computational biology approach
[
84,
Interspecies differences in protein expression do not impact the spatiotemporal regulation of glycoprotein VI mediated activation.

Dunster JL, Unsworth AJ, Bye AP, Haining EJ, Sowa MA, Di Y, et al.

Journal of Thrombosis and Haemostasis. 2020, 18, 485-496

85
Control of Platelet CLEC-2-Mediated Activation by Receptor Clustering and Tyrosine Kinase Signaling.

Martyanov AA, Balabin FA, Dunster JL, Panteleev MA, Gibbins JM, Sveshnikova AN.

Biophysical Journal. 2020, 118, 2641-2655

]
greatly facilitates our understanding of the platelet receptor-function relationship.
Platelet functional responses within arterial thrombus.
Figure 3. Platelet functional responses within arterial thrombus.
Author Contributions: A.N.S. drew the figures, wrote the text and edited the paper; M.G.S. drew the figures; M.A.P. supervised the project, wrote the text and edited the paper. All authors have read and agreed to the published version of the manuscript.
Conflicts of Interest: The authors declare no conflict of interest
Funding: The study was supported by Russian Science Foundation (Grant 21-74-20087).

References of this article:

  1. Hemostasis and thrombosis beyond biochemistry: roles of geometry, flow and diffusion.

    Panteleev MA, Dashkevich NM, Ataullakhanov FI.

    Thrombosis Research. 2015, 136, 699-711

  2. Novel mouse hemostasis model for real-time determination of bleeding time and hemostatic plug composition.

    Getz TM, Piatt R, Petrich BG, Monroe D, Mackman N, Bergmeier W.

    Journal of Thrombosis and Haemostasis . 2015, 13, 417-425

  3. Kinetics of Factor X activation by the membrane-bound complex of Factor IXa and Factor VIIIa.

    Panteleev MA, Saenko EL, Ananyeva NM, Ataullakhanov FI.

    Biochemistry Journal. 2004, 381, 779-794

  4. Hysteresis-like binding of coagulation factors X/Xa to procoagulant activated platelets and phospholipids results from multistep association and membrane-dependent multimerization.

    Podoplelova NA, Sveshnikova AN, Kurasawa JH, Sarafanov AG, Chambost H, Vasil’Ev SA, et al.

    BiomemBiochimica et Biophysica Acta (BBA)-Biomembranesbranes. 2016, 1858, 1216-1227

  5. Platelets and vascular integrity.

    Deppermann C.

    Platelets. 2018, 29, 549-555

  6. Physiological and pathophysiological aspects of blood platelet activation through CLEC-2 receptor.

    Martyanov AA, Kaneva VN, Panteleev MA, Sveshnikova AN.

    Oncohematology. 2018, 13, 83-90

  7. How platelets safeguard vascular integrity: Platelets and vascular integrity.

    Ho-Tin-Noé B, Demers M, Wagner DD.

    Journal of Thrombosis and Haemostasis. 2011, 9, 56-65

  8. Platelet ITAM signaling is critical for vascular integrity in inflammation.

    Boulaftali Y, Hess PR, Getz TM, Cholka A, Stolla M, Mackman N, et al.

    Journal of Clinical Investigation. 2013, 123 (2), 908-916

  9. Editorial: Platelets and Immune Responses During Thromboinflammation.

    Schattner M, Jenne CN, Negrotto S, Ho-Tin-Noe B.

    Frontiers in Immunology. 2020, 11, 1079

  10. he dual role of platelet-innate immune cell interactions in thrombo-inflammation.

    Rayes J, Bourne JH, Brill A, Watson SP.

    Research and Practice in Thrombosis and Haemostasis. 2020, 4, 23-35

  11. Heat-treated human platelet pellet lysate modulates microglia activation, favors wound healing and promotes neuronal differentiation in vitro.

    Nebie O, Barro L, Wu Y-W, Knutson F, Buée L, Devos D, et al.

    Platelets. 2021, 32 (2), 226-237

  12. Platelets and cancer angiogenesis nexus.

    Wojtukiewicz MZ, Sierko E, Hempel D, Tucker SC, Honn KV.

    Cancer and Metastasis Reviews. 2017, 36, 249-262

  13. Platelets and hemostasis.

    Panteleev MA, Sveshnikova AN.

    Oncohematology. 2014, 9, 65-73

  14. Mathematical Techniques for Understanding Platelet Regulation and the Development of New Pharmacological Approaches. In: Gibbins JM, Mahaut-Smith M, editors. Platelets and Megakaryocytes 

    Dunster JL, Panteleev MA, Gibbins JM, Sveshnikova AN.

    Advanced Protocols and Perspectives, New York, NY: Springer. 2018, 4, 255-279

  15. ITIM receptors: more than just inhibitors of platelet activation.

    Coxon CH, Geer MJ, Senis YA.

    Blood. 2017, 129, 3407-3418

  16. Uncoupling ITIM receptor G6b-B from tyrosine phosphatases Shp1 and Shp2 disrupts murine platelet homeostasis.

    Geer MJ, van Geffen JP, Gopalasingam P, Vögtle T, Smith CW, Heising S, et al.

    Blood. 2018, 132, 1413-1425

  17. IκBβ is an essential co-activator for LPS-induced IL-1β transcription in vivo.

    Scheibel M, Klein B, Merkle H, Schulz M, Fritsch R, Greten FR, et al.

    ournal of Experimental Medicine . 2010, 207, 2621-2630

  18. Costimulation, Coinhibition and Cancer.

    Inman BA, Frigola X, Dong H, Kwon ED.

    Current Cancer Drug Targets . 2007, 7, 15-30

  19. A Directed Protein Interaction Network for Investigating Intracellular Signal Transduction.

    Vinayagam A, Stelzl U, Foulle R, Plassmann S, Zenkner M, Timm J, et al.

    Science Signaling. 2011, 4, rs8

  20. Platelet Mechanotransduction.

    Hansen CE, Qiu Y, McCarty OJT, Lam WA.

    Annual Review of Biomedical Engineering. 2018, 20, 253-275

  21. An integrin αIIbβ3 intermediate affinity state mediates biomechanical platelet aggregation.

    Chen Y, Ju LA, Zhou F, Liao J, Xue L, Su QP, et al.

    Nature Materials. 2019, 18, 760-769

  22. Evidence for shear-mediated Ca2+ entry through mechanosensitive cation channels in human platelets and a megakaryocytic cell line.

    Ilkan Z, Wright JR, Goodall AH, Gibbins JM, Jones CI, Mahaut-Smith MP.

    Journal of Biological Chemistry. 2017, 292, 9204-9217

  23. Turbulence Activates Platelet Biogenesis to Enable Clinical Scale Ex Vivo Production.

    Ito Y, Nakamura S, Sugimoto N, Shigemori T, Kato Y, Ohno M, et al.

    Cell. 2018, 174, 636-648

  24. Platelet Integrin αIIbβ3: Mechanisms of Activation and Clustering; Involvement into the Formation of the Thrombus Heterogeneous Structure.

    Kaneva VN, Martyanov AA, Morozova DS, Panteleev MA, Sveshnikova AN.

    Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology. 2019, 13, 97-110

  25. Platelet dense granule secretion plays a critical role in thrombosis and subsequentvascular remodeling in atherosclerotic mice.

    King SM, McNamee RA, Houng AK, Patel R, Brands M, Reed GL.

    Circulation. 2009, 120, 785-791

  26. Selective sorting of alpha-granule proteins.

    Jr JEI, Battinelli EM.

    Journal of Thrombosis and Haemostasis. 2009, 7, 173-176

  27. Clot contraction drives the translocation of procoagulant platelets to thrombus surface.

    Nechipurenko DY, Receveur N, Yakimenko AO, Shepelyuk TO, Yakusheva AA, Kerimov RR, et al.

    Arteriosclerosis, Thrombosis, and Vascular Biology. 2019, 39, 37-47

  28. Kinetics and mechanics of clot contraction are governed by the molecular and cellular composition of the blood.

    Tutwiler V, Litvinov RI, Lozhkin AP, Peshkova AD, Lebedeva T, Ataullakhanov FI, et al.

    Blood. 2016, 127, 149-159

  29. Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions.

    Dong JF, Berndt MC, Schade A, McIntire LV, Andrews RK, López JA.

    Blood. 2001, 97, 162-168

  30. Inherited platelet diseases with normal platelet count: phenotypes, genotypes and diagnostic strategy.

    Nurden P, Stritt S, Favier R, Nurden AT.

    Haematologica. 2021, 106, 337-350

  31. RAP GTPases and platelet integrin signaling.

    Stefanini L, Bergmeier W.

    Platelets. 2019, 30, 41-47

  32. Talin-1 is the principal platelet Rap1 effector of integrin activation.

    Lagarrigue F, Paul DS, Gingras AR, Valadez AJ, Sun H, Lin J, et al.

    Blood. 2020, 136, 1180-1190

  33. Kindlin supports platelet integrin αIIbβ3 activation by interacting with paxillin.

    Gao J, Huang M, Lai J, Mao K, Sun P, Cao Z, et al.

    Journal of Cell Science. 2017, 130, 3764-3775

  34. Rap1-Rac1 circuits potentiate platelet activation.

    Stefanini L, Boulaftali Y, Ouellette TD, Holinstat M, Désiré L, Leblond B, et al.

    Arteriosclerosis, Thrombosis, and Vascular Biology. 2012, 32, 434-441

  35. Platelet integrin α6β1 controls lung metastasis through direct binding to cancer cell-derived ADAM9.

    Mammadova-Bach E, Zigrino P, Brucker C, Bourdon C, Freund M, De Arcangelis A, et al.

    JCI Insight. 2016, 1 (14), e88245

  36. he basement membrane protein nidogen-1 supports platelet adhesion and activation.

    Lakshmanan HHS, Melrose AR, Sepp A-LI, Mitrugno A, Ngo ATP, Khader A, et al.

    Platelets. 2020, 32 (3), 424-428

  37. Platelet Munc13-4 regulates hemostasis, thrombosis and airway inflammation.

    Cardenas EI, Breaux K, Da Q, Flores JR, Ramos MA, Tuvim MJ, et al.

    Haematologica. 2018, 103, 1235-1244

  38. Platelet-specific deletion of SNAP23 ablates granule secretion, substantially inhibiting arterial and venous thrombosis in mice.

    Williams CM, Li Y, Brown E, Poole AW.

    Blood Advances. 2018, 2, 3627-3636

  39. Assessment of the effects of Syk and BTK inhibitors on GPVI-mediated platelet signaling and function.

    Zheng TJ, Lofurno ER, Melrose AR, Lakshmanan HHS, Pang J, Phillips KG, et al.

    American Journal of Physiology: Cell Physiology. 2021, NaN, NaN

  40. A Flow Cytometry-Based Assay for Procoagulant Platelet Polyphosphate.

    Labberton L, Long AT, Gendler SJ, Snozek CL, Stavrou EX, Nickel KF, et al.

    Cytometry Part B: Clinical Cytometry. 2018, 94, 369-373

  41. Platelet polyphosphate induces fibroblast chemotaxis and myofibroblast differentiation.

    Suess PM, Smith SA, Morrissey JH.

    Journal of Thrombosis and Haemostasis. 2020, 18, 3043-3052

  42. Sorting machineries: how platelet-dense granules differ from α-granules.

    Chen Y, Yuan Y, Li W.

    Bioscience Reports. 2018, 38, NaN

  43. The effect of P2Y12 inhibition on platelet activation assessed with aggregation- and flow cytometry-based assays.

    Leunissen TC, Wisman PP, van Holten TC, de Groot PG, Korporaal SJ, Koekman AC, et al.

    Platelets. 2017, 28, 567-575

  44. Diverse functions of protein kinase C isoforms in platelet activation and thrombus formation.

    Harper MT, Poole AW.

    Journal of Thrombosis and Haemostasis. 2010, 8, 454-462

  45. Differential role of protein kinase C delta isoform in agonist-induced dense granule secretion in human platelets.

    Murugappan S, Tuluc F, Dorsam RT, Shankar H, Kunapuli SP.

    Journal of Biological Chemistry. 2004, 279, 2360-2367

  46. Regulation of membrane trafficking by signalling on endosomal and lysosomal membranes.

    Li X, Garrity AG, Xu H.

    Journal of Physiology. 2013, 591, 4389-4401

  47. An early endosome–derived retrograde trafficking pathway promotes secretory granule maturation.

    Ma C-IJ, Yang Y, Kim T, Chen CH, Polevoy G, Vissa M, et al.

    Journal of Cell Biology. 2020, 219, e201808017

  48. Structural analysis of resting mouse platelets by 3D-EM Reveals an unexpected variation in α-granule shape.

    Pokrovskaya I, Tobin M, Desai R, Aronova MA, Kamykowski JA, Zhang G, et al.

    Platelets. 2020, NaN, 1-10

  49. Platelet Releasate Proteome Profiling Reveals a Core Set of Proteins with Low Variance between Healthy Adults.

    Parsons MEM, Szklanna PB, Guerrero JA, Wynne K, Dervin F, O’Connell K, et al.

    Proteomics. 2018, 18, e1800219

  50. Platelet surface-associated activation and secretion-mediated inhibition of coagulation factor XII.

    Zakharova NV, Artemenko EO, Podoplelova NA, Sveshnikova AN, Demina IA, Ataullakhanov FI, et al.

    PloS One. 2015, 10, e0116665

  51. Distinct platelet packaging, release, and surface expression of proangiogenic and antiangiogenic factors on different platelet stimuli.

    Chatterjee M, Huang Z, Zhang W, Jiang L, Hultenby K, Zhu L, et al.

    Blood. 2011, 117, 3907-3911

  52. The platelet release reaction: granules’ constituents, secretion and functions.

    Rendu F, Brohard-Bohn B.

    Platelets. 2001, 12, 261-273

  53. The life cycle of platelet granules.

    Sharda A, Flaumenhaft R.

    F1000Research. 2018, 7, 236

  54. Platelet secretion: From haemostasis to wound healing and beyond.

    Golebiewska EM, Poole AW.

    Blood Reviews. 2015, 29, 153-162

  55. Platelets and platelet-derived factor Va confer hemostatic competence in complete factor V deficiency.

    Bouchard BA, Chapin J, Brummel-Ziedins KE, Durda P, Key NS, Tracy PB.

    Blood. 2015, 125, 3647-3650

  56. Coated-platelets: an emerging component of the procoagulant response.

    Dale GL.

    Journal of Thrombosis and Haemostasis. 2005, 3, 2185-2192

  57. Procoagulant platelets form an α-granule protein-covered “cap” on their surface that promotes their attachment to aggregates.

    Abaeva AA, Canault M, Kotova YN, Obydennyy SI, Yakimenko AO, Podoplelova NA, et al.

    Journal of Biological Chemistry. 2013, 288, 29621-29632

  58. Identification of different proaggregatory abilities of activated platelet subpopulations.

    Yakimenko AO, Verholomova FY, Kotova YN, Ataullakhanov FI, Panteleev MA.

    Biophysical Journal. 2012, 102, 2261-2269

  59. A simple, whole blood method for assessment of platelet function: application to dietary intervention.

    Allman-Farinelli MA, Bendall L, Troy J, Versluis C, Hall D, Favaloro EJ, et al.

    Thrombosis Research. 1998, 90, 163-169

  60. Close relationship between the platelet activation marker CD62 and the granular release of platelet-derived growth factor.

    Graff J, Klinkhardt U, Schini-Kerth VB, Harder S, Franz N, Bassus S, et al.

    Journal of Pharmacology and Experimental Therapeutics. 2002, 300, 952-957

  61. Different G protein-coupled signaling pathways are involved in alpha granule release from human platelets.

    Quinton TM, Murugappan S, Kim S, Jin J, Kunapuli SP.

    Journal of Thrombosis and Haemostasis. 2004, 2, 978-984

  62. Coagulation factors bound to procoagulant platelets concentrate in cap structures to promote clotting.

    Podoplelova NA, Sveshnikova AN, Kotova YN, Eckly A, Receveur N, Nechipurenko DYu, et al.

    Blood. 2016, 128, 1745-1755

  63. Dual Mechanism of Integrin αIIbβ3 Closure in Procoagulant Platelets.

    Mattheij NJA, Gilio K, van Kruchten R, Jobe SM, Wieschhaus AJ, Chishti AH, et al.

    Journal of Biological Chemistry. 2013, 288, 13325-13336

  64. Procoagulant platelets: are they necrotic?

    Jackson SP, Schoenwaelder SM.

    Blood. 2010, 116, 2011-2018

  65. Compartmentalized calcium signaling triggers subpopulation formation upon platelet activation through PAR1.

    Sveshnikova AN, Ataullakhanov FI, Panteleev MA.

    Molecular BioSystems. 2015, 11, 1052-1060

  66. Mechanisms of increased mitochondria-dependent necrosis in Wiskott-Aldrich syndrome platelets.

    Obydennyi SI, Artemenko EO, Sveshnikova AN, Ignatova AA, Varlamova TV, Gambaryan S, et al.

    Haematologica. 2020, 105, 1095-1106

  67. Modulation and pre-amplification of PAR1 signaling by ADP acting via the P2Y12 receptor during platelet subpopulation formation.

    Shakhidzhanov SS, Shaturny VI, Panteleev MA, Sveshnikova AN.

    Biochimica et Biophysica Acta (BBA)-General Subjects. 2015, 1850, 2518-2529

  68. Motor-driven marginal band coiling promotes cell shape change during platelet activation.

    Diagouraga B, Grichine A, Fertin A, Wang J, Khochbin S, Sadoul K.

    Journal of Cell Biology. 2014, 204, 177-185

  69. Tubulin in Platelets: When the Shape Matters.

    Cuenca-Zamora EJ, Ferrer-Marín F, Rivera J, Teruel-Montoya R.

    International Journal of Molecular Sciences. 2019, 20, NaN

  70. Platelet actin nodules are podosome-like structures dependent on Wiskott-Aldrich syndrome protein and ARP2/3 complex.

    Poulter NS, Pollitt AY, Davies A, Malinova D, Nash GB, Hannon MJ, et al.

    Nature Communications. 2015, 6, 7254

  71. latelet Shape Changes during Thrombus Formation: Role of Actin-Based Protrusions.

    Bender M, Palankar R.

    Hamostaseologie. 2021, 41, 14-21

  72. Platelet packing density is an independent regulator of the hemostatic response to injury.

    Mirramezani M, Herbig BA, Stalker TJ, Nettey L, Cooper M, Weisel JW, et al.

    Journal of Thrombosis and Haemostasis. 2018, 16, 973-983

  73. WASP plays a novel role in regulating platelet responses dependent on αIIbβ3 integrin outside-in signalling.

    Shcherbina A, Cooley J, Lutskiy MI, Benarafa C, Gilbert GE, Remold‐O’Donnell E.

    British Journal of Haematology. 2010, 148, 416-427

  74. Platelets, diabetes and myocardial ischemia/reperfusion injury.

    Russo I, Penna C, Musso T, Popara J, Alloatti G, Cavalot F, et al.

    Cardiovascular Diabetology. 2017, 16, NaN

  75. Thromboxane A2: Mechanisms of Synthesis and Intracellular Signaling System of Realization

    Barinov EF.

    Kardiologiia. 2016, 56, 83-90

  76. Is arachidonic acid stimulation really a test for the response to aspirin? Time to think again?

    Olechowski B, Ashby A, Mariathas M, Khanna V, Mahmoudi M, Curzen N.

    Expert Review of Cardiovascular Therapy. 2017, 15, 35-46

  77. Group VIB calcium-independent phospholipase A2 (iPLA2γ) regulates platelet activation, hemostasis and thrombosis in mice.

    Yoda E, Rai K, Ogawa M, Takakura Y, Kuwata H, Suzuki H, et al.

    PLoS One. 2014, 9, e109409

  78. Regulation of platelet activation and coagulation and its role in vascular injury and arterial thrombosis.

    Tomaiuolo M, Brass LF, Stalker TJ.

    Interventional Cardiology Clinics. 2017, 6, 1-12

  79. The critical role of myosin IIA in platelet internal contraction.

    Johnson GJ, Leis LA, Krumwiede MD, White JG.

    Journal of Thrombosis and Haemostasis. 2007, 5, 1516-1529

  80. Calpain Cleavage of Focal Adhesion Proteins Regulates the Cytoskeletal Attachment of Integrin αIIbβ3 (Platelet Glycoprotein IIb/IIIa) and the Cellular Retraction of Fibrin Clots.

    Schoenwaelder SM, Yuan Y, Cooray P, Salem HH, Jackson SP.

    Journal of Biological Chemistry. 1997, 272, 1694-1702

  81. Biphasic myosin II light chain activation during clot retraction.

    Egot M, Kauskot A, Lasne D, Gaussem P, Bachelot-Loza C.

    Thrombosis and Haemostasis. 2013, 110, 1215-1222

  82. Quantitative Morphology of Cerebral Thrombi Related to Intravital Contraction and Clinical Features of Ischemic Stroke.

    Khismatullin RR, Nagaswami C, Shakirova AZ, Vrtková A, Procházka V, Gumulec J, et al.

    Stroke. 2020, 51, 3640-3650

  83. Asymmetrical Forces Dictate the Distribution and Morphology of Platelets in Blood Clots.

    Kovalenko TA, Giraud M-N, Eckly A, Ribba A-S, Proamer F, Fraboulet S, et al.

    Cells. 2021, 10, 584

  84. Interspecies differences in protein expression do not impact the spatiotemporal regulation of glycoprotein VI mediated activation.

    Dunster JL, Unsworth AJ, Bye AP, Haining EJ, Sowa MA, Di Y, et al.

    Journal of Thrombosis and Haemostasis. 2020, 18, 485-496

  85. Control of Platelet CLEC-2-Mediated Activation by Receptor Clustering and Tyrosine Kinase Signaling.

    Martyanov AA, Balabin FA, Dunster JL, Panteleev MA, Gibbins JM, Sveshnikova AN.

    Biophysical Journal. 2020, 118, 2641-2655

  86. Hierarchical organization in the hemostatic response and its relationship to the platelet-signaling network.

    Stalker TJ, Traxler EA, Wu J, Wannemacher KM, Cermignano SL, Voronov R, et al.

    Blood. 2013, 121, 1875-1885